Solas BioVentures

Solas BioVentures is a venture capital firm based in Chattanooga, Tennessee, that backs early-stage opportunities in biopharmaceuticals, medical devices, diagnostics and digital health. The firm provides capital to early-stage companies developing healthcare products and related technologies in the life sciences and medical technology sectors. Since its founding in 2014, Solas BioVentures has focused on supporting startups at the intersection of medicine and technology, helping teams advance products from concept toward clinical development and market readiness.

Lana Caron

Partner

Joshua Eckelberry

Principal

Mark Hackett JD

Co-Founder and Partner

Michael Hoey Ph.D

Partner

Laurent Pacheco

Venture Partner

Scott Rader

Principal and Senior Vice President

Past deals in Tennessee

EirSystems

Seed Round in 2022
EirSystems Inc. is a medical software company established in 2018 and located in Chattanooga, Tennessee. It specializes in developing blockchain-based solutions to enhance the prescription process, particularly focusing on opioid prescriptions. The company's flagship product, the Prescription Abuse Greatly Reduced (P.A.G.R.) system, allows healthcare providers, including doctors and pharmacists, to accurately track the movement of prescriptions, write prescriptions efficiently, and conduct medicine reconciliation. By leveraging distributed ledger technology, EirSystems aims to reduce inefficiencies and improve interoperability in healthcare services, ultimately facilitating better management and oversight of prescription medications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.